Molecular mechanism of ATP-dependent copper transporters
Molecular mechanism of ATP-dependent copper transporters
批准号:
7274118
负责人:
SVETLANA LUTSENKO
金额:
$34.98万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2010-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of these studies is to understand the fundamental mechanisms that regulate the concentration of copper in human cells. Copper plays an essential role in human physiology and is required for embryonic development, respiration, neurotransmitter biosynthesis, and other important physiological processes. Human copper-transporting ATPases ATP7A and ATP7B play a central role in the regulation of intracellular copper. Mutations in these transporters result in the severe metabolic disorders, Menkes disease and Wilson's disease, respectively. Recent studies also suggest that ATP7A (Menkes disease protein, MNKP) and ATP7B (Wilson's disease protein, WNDP) are involved in cellular resistance to platinumbased chemotherapeutic drugs, and therefore could be important pharmacological targets in cancer treatment. Despite the essential role of MNKP and WNDP in human physiology, our knowledge of how these ATP-driven transporters regulate intracellular copper is extremely limited. In the proposed series of experiments, a unique set of biochemical tools established by the PI's laboratory is utilized to dissect specific molecular mechanisms that control the function and regulation of WNDP and MNKP in cells. Four specific aims are proposed. The first objective is to generate a comprehensive picture of copper-dependent regulation of WNDP and MNKP by characterizing the functional roles of the multiple metal-binding sites in the N-terminal domain of these proteins. The second goal is to obtain structural information necessary for an understanding of nucleotide binding by WNDP and MNKP and for the development of specific inhibitors for these transporters. Thirdly, the role of a recently discovered protein Murr1 in the function and regulation of WNDP will be determined using a combination of biochemical and cell biological approaches. The final objective is to dissect the molecular mechanism of the MNKP/WNDP-related cisplatin resistance. These studies will yield important mechanistic information about the regulation of copper in human cells and will contribute to a better understanding and treatment of disorders associated with copper misbalance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HUMAN DISORDERS OF COPPER METABOLISM: RECENT ADVANCES AND MAIN CHALLENGES
-
批准号:8459097
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2013
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Integrative Analysis of Wilson's Disease
-
批准号:9448230
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2012
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Integrative Analysis of Wilson's Disease
-
批准号:8523921
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2012
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Integrative Analysis of Wilson's Disease
-
批准号:8669996
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2012
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Integrative Analysis of Wilson's Disease
-
批准号:9699645
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2012
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Integrative Analysis of Wilson's Disease
-
批准号:8387888
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2012
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular Physiology and Biochemistry of Wilson's disease
-
批准号:8086727
-
项目类别:
-
资助金额:$50.52万
-
财政年份:2010
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Administration
-
批准号:7690609
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2009
-
负责人:SVETLANA LUTSENKO
-
依托单位:
REGULATION OF COPPER EXPORT FROM HUMAN CELLS
-
批准号:7690600
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2009
-
负责人:SVETLANA LUTSENKO
-
依托单位:
THE STRUCTURE OF THE N-NUCLEOTIDE BINDING DOMAIN OF WILSON'S DISEASE ATPASE
-
批准号:7420569
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2006
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Characterization of nuclear proteome in normal and diseased liver
-
批准号:7134091
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2006
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Characterization of nuclear proteome in normal and diseased liver
-
批准号:7267899
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2006
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:7102695
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:8690026
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular Mechanisms of ATP-dependent Copper Transporters
-
批准号:9037279
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:8144880
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:8040090
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:8490358
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular mechanism of ATP-dependent copper transporters
-
批准号:6958723
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
Molecular Mechanisms of Active Copper Transport
-
批准号:10375534
-
项目类别:
-
资助金额:$44.62万
-
财政年份:2005
-
负责人:SVETLANA LUTSENKO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: